Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$210,000.00

Solution NMR studies of functional conformational equilibria of poly(ADP-ribose) polymerase 1 in the presence of drug molecules, interactors, and posttranslational modifications

EF 2024-25

Résumé
Our genetic information is frequently damaged due to the continued and unavoidable exposure of our cell's DNA to energy-rich radiation and reactive molecules. These resulting DNA damage events jeopardize the integrity of the genome and therefore must be fixed immediately to ensure the survival of the cell. PARP proteins are key players in the recognition of damaged DNA. Once PARP recognises DNA damage it starts to synthesise a DNA-like signalling molecule (PAR) and thereby flags the site of DNA damage for repair by dedicated DNA repair proteins. The repair proteins will ultimately correct the DNA damage and thereby ensure cell survival. As PARP proteins play a critical role in repairing DNA damage and thus in maintaining the integrity of the genome, drugs inhibiting these molecules, so called PARP inhibitors (PARPis), can be used to selectively kill cancer cells, which are deficient in other mechanisms of DNA repair. Research on PARPs and PARPis is therefore of exceptional relevance for the development of chemotherapy with less toxic side effects. The activity of PARP is regulated by an intricate interplay of 3 different parts of the protein. Binding of damaged DNA to one of these parts causes the two other parts to lose contact, thus opening PARP and allowing it to produce its signalling molecule to flag the damaged site. Opening of PARP can be influenced by PARPi, with different PARPis resulting in different molecular outcomes. Additionally, PARP can turn itself off by placing the signalling molecule on itself, which forms another layer of regulation. This project will study the opening and closing motions of the different PARP sections together with different PARPis, interaction partners, and PARP self-modifications. These motions will be studied in solution by nuclear magnetic resonance spectroscopy. Insights from this work will benefit the development of new PARPis, potentially leading to new cancer therapies with reduced side effects.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
513610
Name
Roessler Philip
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Solution NMR studies of functional conformational equilibria of poly(ADP-ribose) polymerase 1 in the presence of drug molecules, interactors, and posttranslational modifications
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$210,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cancer; Inhibitors; Nmr Spectroscopy; Parp; Parpi; Poly (Adp-Ribose); Protein Dynamics; Synthetic Lethality
Abstract
Our genetic information is frequently damaged due to the continued and unavoidable exposure of our cell's DNA to energy-rich radiation and reactive molecules. These resulting DNA damage events jeopardize the integrity of the genome and therefore must be fixed immediately to ensure the survival of the cell. PARP proteins are key players in the recognition of damaged DNA. Once PARP recognises DNA damage it starts to synthesise a DNA-like signalling molecule (PAR) and thereby flags the site of DNA damage for repair by dedicated DNA repair proteins. The repair proteins will ultimately correct the DNA damage and thereby ensure cell survival. As PARP proteins play a critical role in repairing DNA damage and thus in maintaining the integrity of the genome, drugs inhibiting these molecules, so called PARP inhibitors (PARPis), can be used to selectively kill cancer cells, which are deficient in other mechanisms of DNA repair. Research on PARPs and PARPis is therefore of exceptional relevance for the development of chemotherapy with less toxic side effects. The activity of PARP is regulated by an intricate interplay of 3 different parts of the protein. Binding of damaged DNA to one of these parts causes the two other parts to lose contact, thus opening PARP and allowing it to produce its signalling molecule to flag the damaged site. Opening of PARP can be influenced by PARPi, with different PARPis resulting in different molecular outcomes. Additionally, PARP can turn itself off by placing the signalling molecule on itself, which forms another layer of regulation. This project will study the opening and closing motions of the different PARP sections together with different PARPis, interaction partners, and PARP self-modifications. These motions will be studied in solution by nuclear magnetic resonance spectroscopy. Insights from this work will benefit the development of new PARPis, potentially leading to new cancer therapies with reduced side effects.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Roessler, Philip
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $210,000~ $0~